BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2021
View Archived Issues
Keymed evaluates CM-310 in phase II for chronic rhinosinusitis with nasal polyposis
Read More
PEP-010 enters first-in-human study in solid tumors
Read More
iBio advances COVID-19 vaccine programs
Read More
Russia authorizes use of single-dose Sputnik Light COVID-19 vaccine
Read More
Sangamo Therapeutics patents chimeric antigen receptors targeting IL-23
Read More
Lead Pharma Holding presents new ERR-alpha inverse agonists
Read More
New TRPA1 antagonists identified at Boehringer Ingelheim
Read More
PTPN11 inhibitors discovered at Hangzhou Rex Pharmaceutical
Read More
Bayer, Deutsches Krebsforschungszentrum present new MAP4K1 inhibitors
Read More
UCB identifies antiepileptic compounds improving on padsevonil
Read More
Study of a new CAIX-targeting radiotracer, [99mTc]PHC-102, for SPECT imaging in ccRCC patients
Read More
SparingVision studies ocular gene therapy SPVN-06 in primates
Read More
GQ-127 shows in vitro and in vivo antitumor activity in uveal melanoma
Read More
Reduced galectin-3 observed in central serous chorioretinopathy
Read More
Allysta Pharmaceutical initiates first-in-human study of ALY-688-SR
Read More
Enrollment ongoing in phase II study of JNJ-40411813 as adjunctive therapy in epilepsy
Read More
NuBiyota starts phase II study of MET-2 in subjects with major depression
Read More
Enrollment begins in phase II study of NeoVax cancer vaccine in patients with CLL
Read More
Telix cleared in Australia to begin phase III study of TLX-591 for metastatic CRPC
Read More
KNP-301 tested in mouse models of AMD
Read More
VIP-236 demonstrates potent antitumor efficacy in xenograft models
Read More
China NMPA approves bevacizumab biosimiilar LY-01008
Read More
Preclinical data presented for the ocular anesthetic AG-920
Read More
Cantargia plans to study CAN-04 with carboplatin/gemcitabine in advanced TNBC
Read More
Phase III FIGARO-DKD cardiovascular outcomes study of finerenone meets primary endpoint
Read More
Findings bolster RAD51 as biomarker for DNA repair deficiency
Read More